Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Profound Medical (PROF) Research & Development (2024 - 2025)

Profound Medical (PROF) has 2 years of Research & Development data on record, last reported at $4.3 million in Q4 2025.

  • For Q4 2025, Research & Development fell 8.11% year-over-year to $4.3 million; the TTM value through Dec 2025 reached $20.6 million, up 21.4%, while the annual FY2025 figure was $20.6 million, 21.4% up from the prior year.
  • Research & Development reached $4.3 million in Q4 2025 per PROF's latest filing, down from $5.4 million in the prior quarter.
  • Across five years, Research & Development topped out at $6.1 million in Q2 2025 and bottomed at $3.9 million in Q1 2024.